For almost two decades, scientists have debated whether sponges or comb jellies are the first animal lineage. Now some are ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

KNOXVILLE, Tenn. (WATE) — Storm Team 6 is monitoring a weather system moving into East Tennessee that could bring wintry weather, including snow, ice, and freezing rain. Although some may be ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...

On Tuesday, Google launched a feature that might matter more than any AI benchmark you've heard about this year. It's called Personal Intelligence, and it does something no competitor can easily ...

A new international study calls for a fundamental reset in how humanity understands and pursues sustainable development. The article is published in the journal Communications Sustainability. The ...

An international research team identified hundreds of genes essential for the development of brain cells, including one gene linked to a severe neurodevelopmental disorder not previously described.

HOUSTON, Texas (KTRK) -- If you've flown out of Bush Airport anytime recently, you know all the construction out there can be frustrating, and that construction is now impacting more than just your ...

A map of over 1,000 neurons, reconstructed from an analysis of one cubic millimeter of mouse brain tissue. Courtesy of The Allen Institute. Made up of 86 billion neurons interacting with each other ...

A Japanese national flag and Asahi Group Holdings flags in front of the company’s headquarters in Tokyo, Japan, on 3 October 2025. Credit: Soichiro Koriyama/Bloomberg via Getty Images Asahi Group ...

NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord injury. NervGen’s investigational peptide therapeutic NVG-291 significantly ...